Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine optimal allergen dose as the lowest concentration eliciting positive reactions in 70-90% of subjects. Frequency of positive, negative, doubtful and irritant reactions, and concordance with a corresponding reference allergens will be captured.


Clinical Trial Description

This is a single-center, randomized study to compare the diagnostic performance and safety of ascending doses (0.10 mg/cm², 0.20 mg/cm² and 0.40 mg/cm²) of hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral®) in 20 adult subjects with a past positive patch test to Lyral® or Fragrance Mix 2. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02028182
Study type Interventional
Source Allerderm
Contact
Status Completed
Phase Phase 2
Start date February 2013
Completion date June 2013

See also
  Status Clinical Trial Phase
Completed NCT00371163 - Molecular and Cellular Characterization of Spongiotic Dermatitis N/A
Completed NCT02028208 - Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study Phase 2
Not yet recruiting NCT04853823 - A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB Phase 1
Recruiting NCT06387472 - DermAI to Evaluate Human Factor of Testing N/A
Completed NCT02700373 - A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers Phase 1
Completed NCT03089775 - Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis Phase 1
Completed NCT04438135 - Children With Aluminium Contact Allergy: Cutaneous Exposure Study N/A
Recruiting NCT06189144 - Testing an Intervention in Irritative Contact Dermatitis N/A
Completed NCT04921163 - Children With Aluminium Contact Allergy: Oral Exposure Study N/A
Not yet recruiting NCT02026700 - Bariederm Cream in Chronic Contact Dermatitis N/A
Completed NCT00824889 - Exploratory Study of Natural Killer Cells in Human Skin N/A
Completed NCT00646867 - Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis N/A
Withdrawn NCT01518348 - Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents Phase 3
Recruiting NCT03705182 - Prevention of Dermatitis in Epoxy Exposed Workers N/A
Terminated NCT03198390 - Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
Completed NCT00614289 - Novel Topical Treatment of Hand Dermatitis (Eczema) Phase 1
Recruiting NCT06331390 - Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis N/A
Completed NCT00640250 - Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response Phase 2
Completed NCT00640614 - Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy Phase 3
Recruiting NCT06177314 - Molecular Diagnosis of Allergic Contact Dermatitis